nodes	percent_of_prediction	percent_of_DWPC	metapath
Brinzolamide—CYP3A4—prostate cancer	0.201	1	CbGaD
Brinzolamide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0681	0.207	CbGbCtD
Brinzolamide—CYP3A4—Bicalutamide—prostate cancer	0.0358	0.109	CbGbCtD
Brinzolamide—CYP3A4—Estramustine—prostate cancer	0.0333	0.101	CbGbCtD
Brinzolamide—CYP3A4—Abiraterone—prostate cancer	0.0297	0.09	CbGbCtD
Brinzolamide—CYP3A4—Flutamide—prostate cancer	0.0297	0.09	CbGbCtD
Brinzolamide—CYP3A4—Cabazitaxel—prostate cancer	0.0219	0.0666	CbGbCtD
Brinzolamide—CYP3A4—Estrone—prostate cancer	0.0214	0.0651	CbGbCtD
Brinzolamide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0191	0.058	CbGbCtD
Brinzolamide—CYP3A4—Conjugated Estrogens—prostate cancer	0.014	0.0426	CbGbCtD
Brinzolamide—CYP3A4—Mitoxantrone—prostate cancer	0.0128	0.0387	CbGbCtD
Brinzolamide—CYP3A4—Estradiol—prostate cancer	0.0123	0.0374	CbGbCtD
Brinzolamide—CYP3A4—Prednisone—prostate cancer	0.0106	0.0321	CbGbCtD
Brinzolamide—CYP3A4—Etoposide—prostate cancer	0.00804	0.0244	CbGbCtD
Brinzolamide—CYP3A4—Docetaxel—prostate cancer	0.00736	0.0223	CbGbCtD
Brinzolamide—CYP3A4—Doxorubicin—prostate cancer	0.00548	0.0166	CbGbCtD
Brinzolamide—CA14—prostate gland—prostate cancer	0.00363	0.0895	CbGeAlD
Brinzolamide—CA14—seminal vesicle—prostate cancer	0.00307	0.0757	CbGeAlD
Brinzolamide—CA7—renal system—prostate cancer	0.00297	0.0733	CbGeAlD
Brinzolamide—CYP3A4—urine—prostate cancer	0.00261	0.0644	CbGeAlD
Brinzolamide—CA5B—prostate gland—prostate cancer	0.00254	0.0626	CbGeAlD
Brinzolamide—CA12—renal system—prostate cancer	0.00193	0.0476	CbGeAlD
Brinzolamide—CA4—prostate gland—prostate cancer	0.00175	0.0432	CbGeAlD
Brinzolamide—CA5B—urethra—prostate cancer	0.0017	0.0419	CbGeAlD
Brinzolamide—CA9—testis—prostate cancer	0.00168	0.0416	CbGeAlD
Brinzolamide—CA1—renal system—prostate cancer	0.00153	0.0377	CbGeAlD
Brinzolamide—CA4—seminal vesicle—prostate cancer	0.00148	0.0366	CbGeAlD
Brinzolamide—CA2—prostate gland—prostate cancer	0.00145	0.0359	CbGeAlD
Brinzolamide—CA2—seminal vesicle—prostate cancer	0.00123	0.0303	CbGeAlD
Brinzolamide—CA4—renal system—prostate cancer	0.00119	0.0295	CbGeAlD
Brinzolamide—CA4—urethra—prostate cancer	0.00117	0.0289	CbGeAlD
Brinzolamide—CA1—bone marrow—prostate cancer	0.00115	0.0285	CbGeAlD
Brinzolamide—CA5B—testis—prostate cancer	0.00112	0.0276	CbGeAlD
Brinzolamide—CA2—epithelium—prostate cancer	0.00107	0.0263	CbGeAlD
Brinzolamide—Dorzolamide—CYP3A4—prostate cancer	0.00102	1	CrCbGaD
Brinzolamide—CA2—renal system—prostate cancer	0.000989	0.0244	CbGeAlD
Brinzolamide—CA4—bone marrow—prostate cancer	0.000902	0.0223	CbGeAlD
Brinzolamide—CA5B—lymph node—prostate cancer	0.00081	0.02	CbGeAlD
Brinzolamide—CA4—testis—prostate cancer	0.000771	0.019	CbGeAlD
Brinzolamide—CA2—bone marrow—prostate cancer	0.000748	0.0185	CbGeAlD
Brinzolamide—CA1—lymph node—prostate cancer	0.000715	0.0177	CbGeAlD
Brinzolamide—CA2—testis—prostate cancer	0.00064	0.0158	CbGeAlD
Brinzolamide—CYP3A4—renal system—prostate cancer	0.000638	0.0158	CbGeAlD
Brinzolamide—CA4—lymph node—prostate cancer	0.000559	0.0138	CbGeAlD
Brinzolamide—CA2—lymph node—prostate cancer	0.000464	0.0114	CbGeAlD
Brinzolamide—Epistaxis—Epirubicin—prostate cancer	9.97e-05	0.000317	CcSEcCtD
Brinzolamide—Vision blurred—Prednisone—prostate cancer	9.96e-05	0.000317	CcSEcCtD
Brinzolamide—Infection—Docetaxel—prostate cancer	9.93e-05	0.000316	CcSEcCtD
Brinzolamide—Sinusitis—Epirubicin—prostate cancer	9.92e-05	0.000315	CcSEcCtD
Brinzolamide—Feeling abnormal—Etoposide—prostate cancer	9.92e-05	0.000315	CcSEcCtD
Brinzolamide—Diarrhoea—Mitoxantrone—prostate cancer	9.9e-05	0.000315	CcSEcCtD
Brinzolamide—Dry mouth—Capecitabine—prostate cancer	9.88e-05	0.000314	CcSEcCtD
Brinzolamide—Vomiting—Estradiol—prostate cancer	9.87e-05	0.000314	CcSEcCtD
Brinzolamide—Nervous system disorder—Docetaxel—prostate cancer	9.81e-05	0.000312	CcSEcCtD
Brinzolamide—Ill-defined disorder—Prednisone—prostate cancer	9.8e-05	0.000312	CcSEcCtD
Brinzolamide—Rash—Estradiol—prostate cancer	9.79e-05	0.000311	CcSEcCtD
Brinzolamide—Infestation NOS—Doxorubicin—prostate cancer	9.78e-05	0.000311	CcSEcCtD
Brinzolamide—Infestation—Doxorubicin—prostate cancer	9.78e-05	0.000311	CcSEcCtD
Brinzolamide—Dermatitis—Estradiol—prostate cancer	9.78e-05	0.000311	CcSEcCtD
Brinzolamide—Tachycardia—Docetaxel—prostate cancer	9.76e-05	0.00031	CcSEcCtD
Brinzolamide—Headache—Estradiol—prostate cancer	9.73e-05	0.000309	CcSEcCtD
Brinzolamide—Skin disorder—Docetaxel—prostate cancer	9.71e-05	0.000309	CcSEcCtD
Brinzolamide—Agitation—Prednisone—prostate cancer	9.71e-05	0.000309	CcSEcCtD
Brinzolamide—Bradycardia—Epirubicin—prostate cancer	9.66e-05	0.000307	CcSEcCtD
Brinzolamide—Infection—Capecitabine—prostate cancer	9.62e-05	0.000306	CcSEcCtD
Brinzolamide—Urticaria—Etoposide—prostate cancer	9.56e-05	0.000304	CcSEcCtD
Brinzolamide—Malaise—Prednisone—prostate cancer	9.53e-05	0.000303	CcSEcCtD
Brinzolamide—Rhinitis—Epirubicin—prostate cancer	9.52e-05	0.000303	CcSEcCtD
Brinzolamide—Conjunctivitis—Doxorubicin—prostate cancer	9.51e-05	0.000302	CcSEcCtD
Brinzolamide—Nervous system disorder—Capecitabine—prostate cancer	9.49e-05	0.000302	CcSEcCtD
Brinzolamide—Vertigo—Prednisone—prostate cancer	9.49e-05	0.000302	CcSEcCtD
Brinzolamide—Tachycardia—Capecitabine—prostate cancer	9.45e-05	0.0003	CcSEcCtD
Brinzolamide—Hypoaesthesia—Epirubicin—prostate cancer	9.45e-05	0.0003	CcSEcCtD
Brinzolamide—Pharyngitis—Epirubicin—prostate cancer	9.42e-05	0.0003	CcSEcCtD
Brinzolamide—Skin disorder—Capecitabine—prostate cancer	9.4e-05	0.000299	CcSEcCtD
Brinzolamide—Urinary tract disorder—Epirubicin—prostate cancer	9.38e-05	0.000298	CcSEcCtD
Brinzolamide—Oedema peripheral—Epirubicin—prostate cancer	9.35e-05	0.000297	CcSEcCtD
Brinzolamide—Hypotension—Docetaxel—prostate cancer	9.34e-05	0.000297	CcSEcCtD
Brinzolamide—Connective tissue disorder—Epirubicin—prostate cancer	9.33e-05	0.000297	CcSEcCtD
Brinzolamide—Urethral disorder—Epirubicin—prostate cancer	9.31e-05	0.000296	CcSEcCtD
Brinzolamide—Hepatobiliary disease—Doxorubicin—prostate cancer	9.25e-05	0.000294	CcSEcCtD
Brinzolamide—Epistaxis—Doxorubicin—prostate cancer	9.23e-05	0.000293	CcSEcCtD
Brinzolamide—Nausea—Estradiol—prostate cancer	9.22e-05	0.000293	CcSEcCtD
Brinzolamide—Vomiting—Mitoxantrone—prostate cancer	9.2e-05	0.000292	CcSEcCtD
Brinzolamide—Sinusitis—Doxorubicin—prostate cancer	9.18e-05	0.000292	CcSEcCtD
Brinzolamide—Visual impairment—Epirubicin—prostate cancer	9.15e-05	0.000291	CcSEcCtD
Brinzolamide—Hypertension—Prednisone—prostate cancer	9.12e-05	0.00029	CcSEcCtD
Brinzolamide—Rash—Mitoxantrone—prostate cancer	9.12e-05	0.00029	CcSEcCtD
Brinzolamide—Dermatitis—Mitoxantrone—prostate cancer	9.11e-05	0.00029	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Docetaxel—prostate cancer	9.11e-05	0.00029	CcSEcCtD
Brinzolamide—Headache—Mitoxantrone—prostate cancer	9.06e-05	0.000288	CcSEcCtD
Brinzolamide—Hypotension—Capecitabine—prostate cancer	9.05e-05	0.000288	CcSEcCtD
Brinzolamide—Insomnia—Docetaxel—prostate cancer	9.04e-05	0.000288	CcSEcCtD
Brinzolamide—Myalgia—Prednisone—prostate cancer	9e-05	0.000286	CcSEcCtD
Brinzolamide—Arthralgia—Prednisone—prostate cancer	9e-05	0.000286	CcSEcCtD
Brinzolamide—Paraesthesia—Docetaxel—prostate cancer	8.98e-05	0.000286	CcSEcCtD
Brinzolamide—Bradycardia—Doxorubicin—prostate cancer	8.94e-05	0.000284	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—prostate cancer	8.93e-05	0.000284	CcSEcCtD
Brinzolamide—Dyspnoea—Docetaxel—prostate cancer	8.91e-05	0.000283	CcSEcCtD
Brinzolamide—Somnolence—Docetaxel—prostate cancer	8.89e-05	0.000283	CcSEcCtD
Brinzolamide—Discomfort—Prednisone—prostate cancer	8.89e-05	0.000283	CcSEcCtD
Brinzolamide—Eye disorder—Epirubicin—prostate cancer	8.87e-05	0.000282	CcSEcCtD
Brinzolamide—Hypersensitivity—Etoposide—prostate cancer	8.86e-05	0.000282	CcSEcCtD
Brinzolamide—Tinnitus—Epirubicin—prostate cancer	8.85e-05	0.000281	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Capecitabine—prostate cancer	8.82e-05	0.00028	CcSEcCtD
Brinzolamide—Cardiac disorder—Epirubicin—prostate cancer	8.81e-05	0.00028	CcSEcCtD
Brinzolamide—Rhinitis—Doxorubicin—prostate cancer	8.81e-05	0.00028	CcSEcCtD
Brinzolamide—Dyspepsia—Docetaxel—prostate cancer	8.8e-05	0.00028	CcSEcCtD
Brinzolamide—Insomnia—Capecitabine—prostate cancer	8.76e-05	0.000278	CcSEcCtD
Brinzolamide—Hypoaesthesia—Doxorubicin—prostate cancer	8.74e-05	0.000278	CcSEcCtD
Brinzolamide—Pharyngitis—Doxorubicin—prostate cancer	8.72e-05	0.000277	CcSEcCtD
Brinzolamide—Paraesthesia—Capecitabine—prostate cancer	8.69e-05	0.000276	CcSEcCtD
Brinzolamide—Decreased appetite—Docetaxel—prostate cancer	8.69e-05	0.000276	CcSEcCtD
Brinzolamide—Urinary tract disorder—Doxorubicin—prostate cancer	8.67e-05	0.000276	CcSEcCtD
Brinzolamide—Oedema peripheral—Doxorubicin—prostate cancer	8.65e-05	0.000275	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Docetaxel—prostate cancer	8.63e-05	0.000275	CcSEcCtD
Brinzolamide—Asthenia—Etoposide—prostate cancer	8.63e-05	0.000275	CcSEcCtD
Brinzolamide—Connective tissue disorder—Doxorubicin—prostate cancer	8.63e-05	0.000274	CcSEcCtD
Brinzolamide—Dyspnoea—Capecitabine—prostate cancer	8.63e-05	0.000274	CcSEcCtD
Brinzolamide—Fatigue—Docetaxel—prostate cancer	8.62e-05	0.000274	CcSEcCtD
Brinzolamide—Angiopathy—Epirubicin—prostate cancer	8.61e-05	0.000274	CcSEcCtD
Brinzolamide—Urethral disorder—Doxorubicin—prostate cancer	8.61e-05	0.000274	CcSEcCtD
Brinzolamide—Nausea—Mitoxantrone—prostate cancer	8.59e-05	0.000273	CcSEcCtD
Brinzolamide—Immune system disorder—Epirubicin—prostate cancer	8.57e-05	0.000273	CcSEcCtD
Brinzolamide—Infection—Prednisone—prostate cancer	8.57e-05	0.000272	CcSEcCtD
Brinzolamide—Mediastinal disorder—Epirubicin—prostate cancer	8.56e-05	0.000272	CcSEcCtD
Brinzolamide—Pain—Docetaxel—prostate cancer	8.55e-05	0.000272	CcSEcCtD
Brinzolamide—Dyspepsia—Capecitabine—prostate cancer	8.52e-05	0.000271	CcSEcCtD
Brinzolamide—Pruritus—Etoposide—prostate cancer	8.51e-05	0.000271	CcSEcCtD
Brinzolamide—Arrhythmia—Epirubicin—prostate cancer	8.48e-05	0.00027	CcSEcCtD
Brinzolamide—Visual impairment—Doxorubicin—prostate cancer	8.46e-05	0.000269	CcSEcCtD
Brinzolamide—Nervous system disorder—Prednisone—prostate cancer	8.46e-05	0.000269	CcSEcCtD
Brinzolamide—Tachycardia—Prednisone—prostate cancer	8.42e-05	0.000268	CcSEcCtD
Brinzolamide—Decreased appetite—Capecitabine—prostate cancer	8.42e-05	0.000268	CcSEcCtD
Brinzolamide—Alopecia—Epirubicin—prostate cancer	8.39e-05	0.000267	CcSEcCtD
Brinzolamide—Skin disorder—Prednisone—prostate cancer	8.38e-05	0.000266	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Capecitabine—prostate cancer	8.36e-05	0.000266	CcSEcCtD
Brinzolamide—Fatigue—Capecitabine—prostate cancer	8.35e-05	0.000265	CcSEcCtD
Brinzolamide—Mental disorder—Epirubicin—prostate cancer	8.32e-05	0.000264	CcSEcCtD
Brinzolamide—Pain—Capecitabine—prostate cancer	8.28e-05	0.000263	CcSEcCtD
Brinzolamide—Erythema—Epirubicin—prostate cancer	8.26e-05	0.000263	CcSEcCtD
Brinzolamide—Malnutrition—Epirubicin—prostate cancer	8.26e-05	0.000263	CcSEcCtD
Brinzolamide—Feeling abnormal—Docetaxel—prostate cancer	8.24e-05	0.000262	CcSEcCtD
Brinzolamide—Diarrhoea—Etoposide—prostate cancer	8.23e-05	0.000262	CcSEcCtD
Brinzolamide—Eye disorder—Doxorubicin—prostate cancer	8.21e-05	0.000261	CcSEcCtD
Brinzolamide—Tinnitus—Doxorubicin—prostate cancer	8.19e-05	0.00026	CcSEcCtD
Brinzolamide—Cardiac disorder—Doxorubicin—prostate cancer	8.15e-05	0.000259	CcSEcCtD
Brinzolamide—Flatulence—Epirubicin—prostate cancer	8.14e-05	0.000259	CcSEcCtD
Brinzolamide—Tension—Epirubicin—prostate cancer	8.11e-05	0.000258	CcSEcCtD
Brinzolamide—Dysgeusia—Epirubicin—prostate cancer	8.09e-05	0.000257	CcSEcCtD
Brinzolamide—Nervousness—Epirubicin—prostate cancer	8.03e-05	0.000255	CcSEcCtD
Brinzolamide—Back pain—Epirubicin—prostate cancer	7.99e-05	0.000254	CcSEcCtD
Brinzolamide—Feeling abnormal—Capecitabine—prostate cancer	7.98e-05	0.000254	CcSEcCtD
Brinzolamide—Angiopathy—Doxorubicin—prostate cancer	7.97e-05	0.000253	CcSEcCtD
Brinzolamide—Dizziness—Etoposide—prostate cancer	7.96e-05	0.000253	CcSEcCtD
Brinzolamide—Muscle spasms—Epirubicin—prostate cancer	7.95e-05	0.000253	CcSEcCtD
Brinzolamide—Immune system disorder—Doxorubicin—prostate cancer	7.93e-05	0.000252	CcSEcCtD
Brinzolamide—Mediastinal disorder—Doxorubicin—prostate cancer	7.92e-05	0.000252	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Prednisone—prostate cancer	7.86e-05	0.00025	CcSEcCtD
Brinzolamide—Arrhythmia—Doxorubicin—prostate cancer	7.85e-05	0.00025	CcSEcCtD
Brinzolamide—Insomnia—Prednisone—prostate cancer	7.8e-05	0.000248	CcSEcCtD
Brinzolamide—Vision blurred—Epirubicin—prostate cancer	7.79e-05	0.000248	CcSEcCtD
Brinzolamide—Alopecia—Doxorubicin—prostate cancer	7.76e-05	0.000247	CcSEcCtD
Brinzolamide—Paraesthesia—Prednisone—prostate cancer	7.74e-05	0.000246	CcSEcCtD
Brinzolamide—Mental disorder—Doxorubicin—prostate cancer	7.7e-05	0.000245	CcSEcCtD
Brinzolamide—Urticaria—Capecitabine—prostate cancer	7.69e-05	0.000245	CcSEcCtD
Brinzolamide—Ill-defined disorder—Epirubicin—prostate cancer	7.67e-05	0.000244	CcSEcCtD
Brinzolamide—Vomiting—Etoposide—prostate cancer	7.65e-05	0.000243	CcSEcCtD
Brinzolamide—Erythema—Doxorubicin—prostate cancer	7.65e-05	0.000243	CcSEcCtD
Brinzolamide—Malnutrition—Doxorubicin—prostate cancer	7.65e-05	0.000243	CcSEcCtD
Brinzolamide—Agitation—Epirubicin—prostate cancer	7.59e-05	0.000241	CcSEcCtD
Brinzolamide—Dyspepsia—Prednisone—prostate cancer	7.59e-05	0.000241	CcSEcCtD
Brinzolamide—Rash—Etoposide—prostate cancer	7.59e-05	0.000241	CcSEcCtD
Brinzolamide—Dermatitis—Etoposide—prostate cancer	7.58e-05	0.000241	CcSEcCtD
Brinzolamide—Headache—Etoposide—prostate cancer	7.54e-05	0.00024	CcSEcCtD
Brinzolamide—Flatulence—Doxorubicin—prostate cancer	7.53e-05	0.00024	CcSEcCtD
Brinzolamide—Tension—Doxorubicin—prostate cancer	7.5e-05	0.000239	CcSEcCtD
Brinzolamide—Decreased appetite—Prednisone—prostate cancer	7.5e-05	0.000238	CcSEcCtD
Brinzolamide—Dysgeusia—Doxorubicin—prostate cancer	7.49e-05	0.000238	CcSEcCtD
Brinzolamide—Malaise—Epirubicin—prostate cancer	7.45e-05	0.000237	CcSEcCtD
Brinzolamide—Fatigue—Prednisone—prostate cancer	7.43e-05	0.000236	CcSEcCtD
Brinzolamide—Nervousness—Doxorubicin—prostate cancer	7.43e-05	0.000236	CcSEcCtD
Brinzolamide—Vertigo—Epirubicin—prostate cancer	7.42e-05	0.000236	CcSEcCtD
Brinzolamide—Back pain—Doxorubicin—prostate cancer	7.4e-05	0.000235	CcSEcCtD
Brinzolamide—Hypersensitivity—Docetaxel—prostate cancer	7.37e-05	0.000234	CcSEcCtD
Brinzolamide—Muscle spasms—Doxorubicin—prostate cancer	7.35e-05	0.000234	CcSEcCtD
Brinzolamide—Palpitations—Epirubicin—prostate cancer	7.3e-05	0.000232	CcSEcCtD
Brinzolamide—Cough—Epirubicin—prostate cancer	7.21e-05	0.000229	CcSEcCtD
Brinzolamide—Vision blurred—Doxorubicin—prostate cancer	7.21e-05	0.000229	CcSEcCtD
Brinzolamide—Asthenia—Docetaxel—prostate cancer	7.17e-05	0.000228	CcSEcCtD
Brinzolamide—Nausea—Etoposide—prostate cancer	7.15e-05	0.000227	CcSEcCtD
Brinzolamide—Hypertension—Epirubicin—prostate cancer	7.13e-05	0.000227	CcSEcCtD
Brinzolamide—Hypersensitivity—Capecitabine—prostate cancer	7.13e-05	0.000227	CcSEcCtD
Brinzolamide—Feeling abnormal—Prednisone—prostate cancer	7.11e-05	0.000226	CcSEcCtD
Brinzolamide—Ill-defined disorder—Doxorubicin—prostate cancer	7.09e-05	0.000226	CcSEcCtD
Brinzolamide—Pruritus—Docetaxel—prostate cancer	7.07e-05	0.000225	CcSEcCtD
Brinzolamide—Myalgia—Epirubicin—prostate cancer	7.04e-05	0.000224	CcSEcCtD
Brinzolamide—Chest pain—Epirubicin—prostate cancer	7.04e-05	0.000224	CcSEcCtD
Brinzolamide—Arthralgia—Epirubicin—prostate cancer	7.04e-05	0.000224	CcSEcCtD
Brinzolamide—Agitation—Doxorubicin—prostate cancer	7.03e-05	0.000223	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—prostate cancer	6.99e-05	0.000222	CcSEcCtD
Brinzolamide—Discomfort—Epirubicin—prostate cancer	6.95e-05	0.000221	CcSEcCtD
Brinzolamide—Asthenia—Capecitabine—prostate cancer	6.95e-05	0.000221	CcSEcCtD
Brinzolamide—Malaise—Doxorubicin—prostate cancer	6.9e-05	0.000219	CcSEcCtD
Brinzolamide—Dry mouth—Epirubicin—prostate cancer	6.88e-05	0.000219	CcSEcCtD
Brinzolamide—Vertigo—Doxorubicin—prostate cancer	6.87e-05	0.000218	CcSEcCtD
Brinzolamide—Urticaria—Prednisone—prostate cancer	6.85e-05	0.000218	CcSEcCtD
Brinzolamide—Pruritus—Capecitabine—prostate cancer	6.85e-05	0.000218	CcSEcCtD
Brinzolamide—Diarrhoea—Docetaxel—prostate cancer	6.84e-05	0.000218	CcSEcCtD
Brinzolamide—Palpitations—Doxorubicin—prostate cancer	6.76e-05	0.000215	CcSEcCtD
Brinzolamide—Infection—Epirubicin—prostate cancer	6.7e-05	0.000213	CcSEcCtD
Brinzolamide—Cough—Doxorubicin—prostate cancer	6.67e-05	0.000212	CcSEcCtD
Brinzolamide—Diarrhoea—Capecitabine—prostate cancer	6.62e-05	0.000211	CcSEcCtD
Brinzolamide—Nervous system disorder—Epirubicin—prostate cancer	6.61e-05	0.00021	CcSEcCtD
Brinzolamide—Dizziness—Docetaxel—prostate cancer	6.61e-05	0.00021	CcSEcCtD
Brinzolamide—Hypertension—Doxorubicin—prostate cancer	6.6e-05	0.00021	CcSEcCtD
Brinzolamide—Tachycardia—Epirubicin—prostate cancer	6.58e-05	0.000209	CcSEcCtD
Brinzolamide—Skin disorder—Epirubicin—prostate cancer	6.55e-05	0.000208	CcSEcCtD
Brinzolamide—Chest pain—Doxorubicin—prostate cancer	6.51e-05	0.000207	CcSEcCtD
Brinzolamide—Myalgia—Doxorubicin—prostate cancer	6.51e-05	0.000207	CcSEcCtD
Brinzolamide—Arthralgia—Doxorubicin—prostate cancer	6.51e-05	0.000207	CcSEcCtD
Brinzolamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—prostate cancer	6.47e-05	0.000206	CcSEcCtD
Brinzolamide—Discomfort—Doxorubicin—prostate cancer	6.43e-05	0.000205	CcSEcCtD
Brinzolamide—Dizziness—Capecitabine—prostate cancer	6.4e-05	0.000204	CcSEcCtD
Brinzolamide—Dry mouth—Doxorubicin—prostate cancer	6.37e-05	0.000202	CcSEcCtD
Brinzolamide—Vomiting—Docetaxel—prostate cancer	6.36e-05	0.000202	CcSEcCtD
Brinzolamide—Hypersensitivity—Prednisone—prostate cancer	6.35e-05	0.000202	CcSEcCtD
Brinzolamide—Rash—Docetaxel—prostate cancer	6.3e-05	0.0002	CcSEcCtD
Brinzolamide—Hypotension—Epirubicin—prostate cancer	6.3e-05	0.0002	CcSEcCtD
Brinzolamide—Dermatitis—Docetaxel—prostate cancer	6.3e-05	0.0002	CcSEcCtD
Brinzolamide—Headache—Docetaxel—prostate cancer	6.26e-05	0.000199	CcSEcCtD
Brinzolamide—Infection—Doxorubicin—prostate cancer	6.2e-05	0.000197	CcSEcCtD
Brinzolamide—Asthenia—Prednisone—prostate cancer	6.19e-05	0.000197	CcSEcCtD
Brinzolamide—Vomiting—Capecitabine—prostate cancer	6.16e-05	0.000196	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Epirubicin—prostate cancer	6.14e-05	0.000195	CcSEcCtD
Brinzolamide—Nervous system disorder—Doxorubicin—prostate cancer	6.12e-05	0.000195	CcSEcCtD
Brinzolamide—Rash—Capecitabine—prostate cancer	6.1e-05	0.000194	CcSEcCtD
Brinzolamide—Pruritus—Prednisone—prostate cancer	6.1e-05	0.000194	CcSEcCtD
Brinzolamide—Insomnia—Epirubicin—prostate cancer	6.1e-05	0.000194	CcSEcCtD
Brinzolamide—Dermatitis—Capecitabine—prostate cancer	6.1e-05	0.000194	CcSEcCtD
Brinzolamide—Tachycardia—Doxorubicin—prostate cancer	6.09e-05	0.000194	CcSEcCtD
Brinzolamide—Headache—Capecitabine—prostate cancer	6.07e-05	0.000193	CcSEcCtD
Brinzolamide—Skin disorder—Doxorubicin—prostate cancer	6.06e-05	0.000193	CcSEcCtD
Brinzolamide—Paraesthesia—Epirubicin—prostate cancer	6.06e-05	0.000193	CcSEcCtD
Brinzolamide—Dyspnoea—Epirubicin—prostate cancer	6.01e-05	0.000191	CcSEcCtD
Brinzolamide—Somnolence—Epirubicin—prostate cancer	6e-05	0.000191	CcSEcCtD
Brinzolamide—Nausea—Docetaxel—prostate cancer	5.94e-05	0.000189	CcSEcCtD
Brinzolamide—Dyspepsia—Epirubicin—prostate cancer	5.94e-05	0.000189	CcSEcCtD
Brinzolamide—Diarrhoea—Prednisone—prostate cancer	5.9e-05	0.000188	CcSEcCtD
Brinzolamide—Decreased appetite—Epirubicin—prostate cancer	5.86e-05	0.000186	CcSEcCtD
Brinzolamide—Hypotension—Doxorubicin—prostate cancer	5.83e-05	0.000185	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Epirubicin—prostate cancer	5.82e-05	0.000185	CcSEcCtD
Brinzolamide—Fatigue—Epirubicin—prostate cancer	5.81e-05	0.000185	CcSEcCtD
Brinzolamide—Pain—Epirubicin—prostate cancer	5.77e-05	0.000183	CcSEcCtD
Brinzolamide—Nausea—Capecitabine—prostate cancer	5.75e-05	0.000183	CcSEcCtD
Brinzolamide—Dizziness—Prednisone—prostate cancer	5.7e-05	0.000181	CcSEcCtD
Brinzolamide—Musculoskeletal discomfort—Doxorubicin—prostate cancer	5.69e-05	0.000181	CcSEcCtD
Brinzolamide—Insomnia—Doxorubicin—prostate cancer	5.64e-05	0.000179	CcSEcCtD
Brinzolamide—Paraesthesia—Doxorubicin—prostate cancer	5.6e-05	0.000178	CcSEcCtD
Brinzolamide—Dyspnoea—Doxorubicin—prostate cancer	5.56e-05	0.000177	CcSEcCtD
Brinzolamide—Feeling abnormal—Epirubicin—prostate cancer	5.56e-05	0.000177	CcSEcCtD
Brinzolamide—Somnolence—Doxorubicin—prostate cancer	5.55e-05	0.000176	CcSEcCtD
Brinzolamide—Dyspepsia—Doxorubicin—prostate cancer	5.49e-05	0.000175	CcSEcCtD
Brinzolamide—Vomiting—Prednisone—prostate cancer	5.48e-05	0.000174	CcSEcCtD
Brinzolamide—Rash—Prednisone—prostate cancer	5.44e-05	0.000173	CcSEcCtD
Brinzolamide—Dermatitis—Prednisone—prostate cancer	5.43e-05	0.000173	CcSEcCtD
Brinzolamide—Decreased appetite—Doxorubicin—prostate cancer	5.42e-05	0.000173	CcSEcCtD
Brinzolamide—Headache—Prednisone—prostate cancer	5.4e-05	0.000172	CcSEcCtD
Brinzolamide—Gastrointestinal disorder—Doxorubicin—prostate cancer	5.39e-05	0.000171	CcSEcCtD
Brinzolamide—Fatigue—Doxorubicin—prostate cancer	5.38e-05	0.000171	CcSEcCtD
Brinzolamide—Urticaria—Epirubicin—prostate cancer	5.36e-05	0.00017	CcSEcCtD
Brinzolamide—Pain—Doxorubicin—prostate cancer	5.34e-05	0.00017	CcSEcCtD
Brinzolamide—Feeling abnormal—Doxorubicin—prostate cancer	5.14e-05	0.000164	CcSEcCtD
Brinzolamide—Nausea—Prednisone—prostate cancer	5.12e-05	0.000163	CcSEcCtD
Brinzolamide—Hypersensitivity—Epirubicin—prostate cancer	4.97e-05	0.000158	CcSEcCtD
Brinzolamide—Urticaria—Doxorubicin—prostate cancer	4.96e-05	0.000158	CcSEcCtD
Brinzolamide—Asthenia—Epirubicin—prostate cancer	4.84e-05	0.000154	CcSEcCtD
Brinzolamide—Pruritus—Epirubicin—prostate cancer	4.77e-05	0.000152	CcSEcCtD
Brinzolamide—Diarrhoea—Epirubicin—prostate cancer	4.61e-05	0.000147	CcSEcCtD
Brinzolamide—Hypersensitivity—Doxorubicin—prostate cancer	4.6e-05	0.000146	CcSEcCtD
Brinzolamide—Asthenia—Doxorubicin—prostate cancer	4.48e-05	0.000142	CcSEcCtD
Brinzolamide—Dizziness—Epirubicin—prostate cancer	4.46e-05	0.000142	CcSEcCtD
Brinzolamide—Pruritus—Doxorubicin—prostate cancer	4.42e-05	0.00014	CcSEcCtD
Brinzolamide—Vomiting—Epirubicin—prostate cancer	4.29e-05	0.000136	CcSEcCtD
Brinzolamide—Diarrhoea—Doxorubicin—prostate cancer	4.27e-05	0.000136	CcSEcCtD
Brinzolamide—Rash—Epirubicin—prostate cancer	4.25e-05	0.000135	CcSEcCtD
Brinzolamide—Dermatitis—Epirubicin—prostate cancer	4.25e-05	0.000135	CcSEcCtD
Brinzolamide—Headache—Epirubicin—prostate cancer	4.23e-05	0.000134	CcSEcCtD
Brinzolamide—Dizziness—Doxorubicin—prostate cancer	4.13e-05	0.000131	CcSEcCtD
Brinzolamide—Nausea—Epirubicin—prostate cancer	4.01e-05	0.000127	CcSEcCtD
Brinzolamide—Vomiting—Doxorubicin—prostate cancer	3.97e-05	0.000126	CcSEcCtD
Brinzolamide—Rash—Doxorubicin—prostate cancer	3.93e-05	0.000125	CcSEcCtD
Brinzolamide—Dermatitis—Doxorubicin—prostate cancer	3.93e-05	0.000125	CcSEcCtD
Brinzolamide—Headache—Doxorubicin—prostate cancer	3.91e-05	0.000124	CcSEcCtD
Brinzolamide—Nausea—Doxorubicin—prostate cancer	3.71e-05	0.000118	CcSEcCtD
Brinzolamide—CA9—Metabolism—GGT1—prostate cancer	2.62e-05	0.000232	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CD—prostate cancer	2.6e-05	0.00023	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—TYMS—prostate cancer	2.59e-05	0.00023	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NCOA1—prostate cancer	2.58e-05	0.000228	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GGT1—prostate cancer	2.58e-05	0.000228	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—GSTM1—prostate cancer	2.56e-05	0.000227	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—INS—prostate cancer	2.55e-05	0.000225	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—INS—prostate cancer	2.55e-05	0.000225	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP19A1—prostate cancer	2.54e-05	0.000225	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—NCOA1—prostate cancer	2.54e-05	0.000225	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CYP1A1—prostate cancer	2.54e-05	0.000224	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CD—prostate cancer	2.53e-05	0.000224	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CD—prostate cancer	2.53e-05	0.000224	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—LPL—prostate cancer	2.52e-05	0.000223	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—ERCC2—prostate cancer	2.52e-05	0.000223	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP19A1—prostate cancer	2.5e-05	0.000221	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—CREBBP—prostate cancer	2.49e-05	0.000221	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—CREBBP—prostate cancer	2.49e-05	0.000221	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CG—prostate cancer	2.49e-05	0.00022	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—TYMS—prostate cancer	2.49e-05	0.00022	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP19A1—prostate cancer	2.47e-05	0.000218	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—GSTM1—prostate cancer	2.46e-05	0.000218	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—RXRA—prostate cancer	2.45e-05	0.000217	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—NOS3—prostate cancer	2.45e-05	0.000217	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CYP1A1—prostate cancer	2.43e-05	0.000215	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—RXRA—prostate cancer	2.42e-05	0.000214	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—LPL—prostate cancer	2.41e-05	0.000214	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—ERCC2—prostate cancer	2.41e-05	0.000213	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—NOS3—prostate cancer	2.39e-05	0.000212	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—NOS3—prostate cancer	2.39e-05	0.000212	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—MTHFR—prostate cancer	2.36e-05	0.000209	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CD—prostate cancer	2.36e-05	0.000209	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CD—prostate cancer	2.36e-05	0.000209	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—COMT—prostate cancer	2.36e-05	0.000209	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—INS—prostate cancer	2.36e-05	0.000209	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTP1—prostate cancer	2.35e-05	0.000208	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CYP1A1—prostate cancer	2.33e-05	0.000206	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—COMT—prostate cancer	2.33e-05	0.000206	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PPARA—prostate cancer	2.32e-05	0.000205	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTP1—prostate cancer	2.32e-05	0.000205	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ITPR1—prostate cancer	2.31e-05	0.000205	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—ERCC2—prostate cancer	2.31e-05	0.000205	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—CREBBP—prostate cancer	2.31e-05	0.000204	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—COMT—prostate cancer	2.29e-05	0.000203	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTP1—prostate cancer	2.28e-05	0.000202	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—MTHFR—prostate cancer	2.27e-05	0.000201	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CB—prostate cancer	2.26e-05	0.0002	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTGS2—prostate cancer	2.24e-05	0.000199	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—NOS3—prostate cancer	2.23e-05	0.000197	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—NOS3—prostate cancer	2.23e-05	0.000197	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PPARA—prostate cancer	2.22e-05	0.000197	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CB—prostate cancer	2.21e-05	0.000195	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CB—prostate cancer	2.21e-05	0.000195	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CD—prostate cancer	2.19e-05	0.000194	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—TYMS—prostate cancer	2.19e-05	0.000193	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTGS2—prostate cancer	2.19e-05	0.000193	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTGS2—prostate cancer	2.19e-05	0.000193	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CAV1—prostate cancer	2.18e-05	0.000193	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—MTHFR—prostate cancer	2.17e-05	0.000192	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—GSTM1—prostate cancer	2.16e-05	0.000191	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PPARA—prostate cancer	2.13e-05	0.000189	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—GSTM1—prostate cancer	2.13e-05	0.000188	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—LPL—prostate cancer	2.12e-05	0.000188	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—GSTM1—prostate cancer	2.1e-05	0.000186	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CAV1—prostate cancer	2.09e-05	0.000185	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—NOS3—prostate cancer	2.07e-05	0.000183	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CB—prostate cancer	2.06e-05	0.000182	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CB—prostate cancer	2.06e-05	0.000182	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CYP1A1—prostate cancer	2.05e-05	0.000181	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTGS2—prostate cancer	2.04e-05	0.000181	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTGS2—prostate cancer	2.04e-05	0.000181	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—ERCC2—prostate cancer	2.03e-05	0.00018	CbGpPWpGaD
Brinzolamide—CYP3A4—Biological oxidations—CYP1A1—prostate cancer	2.02e-05	0.000178	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CAV1—prostate cancer	2e-05	0.000177	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HAO1—prostate cancer	1.99e-05	0.000176	CbGpPWpGaD
Brinzolamide—CYP3A4—Metapathway biotransformation—CYP1A1—prostate cancer	1.99e-05	0.000176	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CG—prostate cancer	1.99e-05	0.000176	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PTEN—prostate cancer	1.96e-05	0.000173	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—MTHFR—prostate cancer	1.91e-05	0.000169	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CB—prostate cancer	1.91e-05	0.000169	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PTEN—prostate cancer	1.91e-05	0.000169	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PTEN—prostate cancer	1.91e-05	0.000169	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CG—prostate cancer	1.9e-05	0.000169	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTGS2—prostate cancer	1.89e-05	0.000167	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—INS—prostate cancer	1.88e-05	0.000166	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PPARA—prostate cancer	1.87e-05	0.000166	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—EP300—prostate cancer	1.87e-05	0.000165	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—CREBBP—prostate cancer	1.84e-05	0.000163	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CG—prostate cancer	1.83e-05	0.000162	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—EP300—prostate cancer	1.82e-05	0.000161	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—EP300—prostate cancer	1.82e-05	0.000161	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—INS—prostate cancer	1.8e-05	0.00016	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PTEN—prostate cancer	1.78e-05	0.000158	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PTEN—prostate cancer	1.78e-05	0.000158	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—CREBBP—prostate cancer	1.77e-05	0.000156	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CAV1—prostate cancer	1.76e-05	0.000156	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CD—prostate cancer	1.75e-05	0.000155	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—INS—prostate cancer	1.73e-05	0.000153	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—EP300—prostate cancer	1.7e-05	0.00015	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—EP300—prostate cancer	1.7e-05	0.00015	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—CREBBP—prostate cancer	1.69e-05	0.00015	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CD—prostate cancer	1.67e-05	0.000148	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PTEN—prostate cancer	1.65e-05	0.000146	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—NOS3—prostate cancer	1.65e-05	0.000146	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PSAT1—prostate cancer	1.62e-05	0.000144	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TST—prostate cancer	1.62e-05	0.000144	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CBR1—prostate cancer	1.62e-05	0.000144	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GRHL1—prostate cancer	1.62e-05	0.000144	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ADI1—prostate cancer	1.62e-05	0.000144	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CSAD—prostate cancer	1.62e-05	0.000144	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CG—prostate cancer	1.61e-05	0.000142	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CD—prostate cancer	1.61e-05	0.000142	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—NOS3—prostate cancer	1.58e-05	0.00014	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—EP300—prostate cancer	1.57e-05	0.000139	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CB—prostate cancer	1.52e-05	0.000135	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—INS—prostate cancer	1.52e-05	0.000134	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—NOS3—prostate cancer	1.52e-05	0.000134	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.51e-05	0.000133	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.51e-05	0.000133	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GRHPR—prostate cancer	1.51e-05	0.000133	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CKMT2—prostate cancer	1.51e-05	0.000133	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTGS2—prostate cancer	1.51e-05	0.000133	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—CREBBP—prostate cancer	1.49e-05	0.000132	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CB—prostate cancer	1.46e-05	0.000129	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTGS2—prostate cancer	1.45e-05	0.000128	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AOX1—prostate cancer	1.42e-05	0.000126	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM3—prostate cancer	1.42e-05	0.000126	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAGLU—prostate cancer	1.42e-05	0.000126	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.42e-05	0.000126	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.42e-05	0.000126	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PGAM2—prostate cancer	1.42e-05	0.000126	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—RFK—prostate cancer	1.42e-05	0.000126	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CD—prostate cancer	1.41e-05	0.000125	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CB—prostate cancer	1.4e-05	0.000124	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTGS2—prostate cancer	1.39e-05	0.000123	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—PIK3CA—prostate cancer	1.38e-05	0.000122	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—PIK3CA—prostate cancer	1.35e-05	0.000119	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—PIK3CA—prostate cancer	1.35e-05	0.000119	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AMACR—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—DEGS1—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAT1—prostate cancer	1.34e-05	0.000119	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—NOS3—prostate cancer	1.33e-05	0.000118	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PTEN—prostate cancer	1.32e-05	0.000116	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD17B1—prostate cancer	1.28e-05	0.000114	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PTEN—prostate cancer	1.26e-05	0.000112	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—PIK3CA—prostate cancer	1.26e-05	0.000111	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—PIK3CA—prostate cancer	1.26e-05	0.000111	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—EP300—prostate cancer	1.25e-05	0.000111	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CB—prostate cancer	1.23e-05	0.000109	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTGS2—prostate cancer	1.22e-05	0.000108	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PTEN—prostate cancer	1.21e-05	0.000107	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—EP300—prostate cancer	1.2e-05	0.000106	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—PIK3CA—prostate cancer	1.16e-05	0.000103	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—EP300—prostate cancer	1.15e-05	0.000102	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—B4GALT4—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HPGD—prostate cancer	1.14e-05	0.000101	CbGpPWpGaD
Brinzolamide—CA14—Metabolism—AKT1—prostate cancer	1.13e-05	9.98e-05	CbGpPWpGaD
Brinzolamide—CA6—Metabolism—AKT1—prostate cancer	1.1e-05	9.72e-05	CbGpPWpGaD
Brinzolamide—CA5A—Metabolism—AKT1—prostate cancer	1.1e-05	9.72e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	1.08e-05	9.51e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PTEN—prostate cancer	1.06e-05	9.4e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTAP—prostate cancer	1.05e-05	9.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP7B1—prostate cancer	1.05e-05	9.25e-05	CbGpPWpGaD
Brinzolamide—CA7—Metabolism—AKT1—prostate cancer	1.03e-05	9.08e-05	CbGpPWpGaD
Brinzolamide—CA5B—Metabolism—AKT1—prostate cancer	1.03e-05	9.08e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SRD5A1—prostate cancer	1.02e-05	9.02e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SULT1E1—prostate cancer	1.02e-05	9.02e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—EP300—prostate cancer	1.01e-05	8.97e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD17B3—prostate cancer	9.72e-06	8.6e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ACSL4—prostate cancer	9.72e-06	8.6e-05	CbGpPWpGaD
Brinzolamide—CA12—Metabolism—AKT1—prostate cancer	9.51e-06	8.41e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ARG2—prostate cancer	9.32e-06	8.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UMPS—prostate cancer	9.32e-06	8.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PHGDH—prostate cancer	9.32e-06	8.25e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—PIK3CA—prostate cancer	9.28e-06	8.21e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LDHB—prostate cancer	9.14e-06	8.09e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP3A5—prostate cancer	8.97e-06	7.94e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—PIK3CA—prostate cancer	8.9e-06	7.87e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TCN2—prostate cancer	8.67e-06	7.67e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA3—prostate cancer	8.67e-06	7.67e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PDHA1—prostate cancer	8.67e-06	7.67e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—UCP3—prostate cancer	8.67e-06	7.67e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—PIK3CA—prostate cancer	8.53e-06	7.55e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC22A3—prostate cancer	8.27e-06	7.31e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD3B1—prostate cancer	8.27e-06	7.31e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA4—prostate cancer	7.93e-06	7.01e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TBXAS1—prostate cancer	7.93e-06	7.01e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA2—prostate cancer	7.72e-06	6.83e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SULT1A1—prostate cancer	7.63e-06	6.75e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ABCG5—prostate cancer	7.63e-06	6.75e-05	CbGpPWpGaD
Brinzolamide—CA4—Metabolism—AKT1—prostate cancer	7.58e-06	6.71e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—PIK3CA—prostate cancer	7.5e-06	6.63e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTA1—prostate cancer	7.45e-06	6.59e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NAT2—prostate cancer	7.37e-06	6.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTO1—prostate cancer	7.37e-06	6.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HSD3B2—prostate cancer	7.37e-06	6.52e-05	CbGpPWpGaD
Brinzolamide—CA2—Metabolism—AKT1—prostate cancer	7.27e-06	6.43e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PLCB2—prostate cancer	7.06e-06	6.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2C18—prostate cancer	7.06e-06	6.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LRP2—prostate cancer	7.06e-06	6.25e-05	CbGpPWpGaD
Brinzolamide—CA1—Metabolism—AKT1—prostate cancer	6.97e-06	6.16e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—P4HB—prostate cancer	6.93e-06	6.13e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC22A1—prostate cancer	6.74e-06	5.96e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SULT2A1—prostate cancer	6.57e-06	5.81e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MED12—prostate cancer	6.46e-06	5.72e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GNG5—prostate cancer	6.41e-06	5.67e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOA3—prostate cancer	6.17e-06	5.46e-05	CbGpPWpGaD
Brinzolamide—CA9—Metabolism—AKT1—prostate cancer	6.13e-06	5.42e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—HPGDS—prostate cancer	5.89e-06	5.21e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2C19—prostate cancer	5.85e-06	5.18e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTT1—prostate cancer	5.71e-06	5.06e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ACHE—prostate cancer	5.71e-06	5.06e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2A6—prostate cancer	5.65e-06	5e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKR1C3—prostate cancer	5.49e-06	4.86e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PRKACB—prostate cancer	5.46e-06	4.84e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP17A1—prostate cancer	5.41e-06	4.79e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOA2—prostate cancer	5.15e-06	4.56e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—SLC5A5—prostate cancer	4.92e-06	4.35e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP2E1—prostate cancer	4.8e-06	4.25e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NQO1—prostate cancer	4.75e-06	4.2e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TH—prostate cancer	4.68e-06	4.14e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1B1—prostate cancer	4.55e-06	4.03e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GGT1—prostate cancer	4.41e-06	3.9e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NCOA1—prostate cancer	4.34e-06	3.84e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP19A1—prostate cancer	4.28e-06	3.79e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—RXRA—prostate cancer	4.13e-06	3.65e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—COMT—prostate cancer	3.98e-06	3.52e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTP1—prostate cancer	3.96e-06	3.5e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ITPR1—prostate cancer	3.9e-06	3.45e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—TYMS—prostate cancer	3.68e-06	3.26e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—GSTM1—prostate cancer	3.64e-06	3.22e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—LPL—prostate cancer	3.57e-06	3.16e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CYP1A1—prostate cancer	3.45e-06	3.05e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—ERCC2—prostate cancer	3.42e-06	3.03e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—MTHFR—prostate cancer	3.22e-06	2.85e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PPARA—prostate cancer	3.16e-06	2.79e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CAV1—prostate cancer	2.97e-06	2.62e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.7e-06	2.39e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—INS—prostate cancer	2.56e-06	2.26e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—CREBBP—prostate cancer	2.51e-06	2.22e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CD—prostate cancer	2.38e-06	2.1e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—NOS3—prostate cancer	2.24e-06	1.98e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CB—prostate cancer	2.07e-06	1.83e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTGS2—prostate cancer	2.05e-06	1.82e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PTEN—prostate cancer	1.79e-06	1.58e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—EP300—prostate cancer	1.71e-06	1.51e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—PIK3CA—prostate cancer	1.26e-06	1.12e-05	CbGpPWpGaD
Brinzolamide—CYP3A4—Metabolism—AKT1—prostate cancer	1.03e-06	9.12e-06	CbGpPWpGaD
